Back to today’s briefing

Story perspectives

Health Shake-Up: New CDC Advisory, BioNTech's $1.25B Deal

6/12/2025

25 5

Summary

Story summary

Health Secretary Robert F. Kennedy Jr. has shaken things up at the CDC by appointing a new vaccine advisory committee, dismissing the old members. In a significant move in the pharmaceutical world, BioNTech is set to acquire German drug developer CureVac for a whopping $1.25 billion. Meanwhile, Senator Bill Cassidy is advocating for a “most-favored nation” pricing policy to make prescription drugs more affordable.

1 of 1

Story summary

Health Secretary Robert F. Kennedy Jr. has shaken things up at the CDC by appointing a new vaccine advisory committee, dismissing the old members. In a significant move in the pharmaceutical world, BioNTech is set to acquire German drug developer CureVac for a whopping $1.25 billion. Meanwhile, Senator Bill Cassidy is advocating for a “most-favored nation” pricing policy to make prescription drugs more affordable.